XML 88 R52.htm IDEA: XBRL DOCUMENT
v3.22.4

Share capital and Contributed Surplus (Tables) | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2020 | Sep. 30, 2022
Disclosure of classes of share capital [abstract] |  |
Disclosure of issued common shares [Table Text Block] |
|  | Number |  |  | Issued Price |  |  | Amount |
Outstanding at December 2018 |  | 3 |  | $ | 66.67 |  | $ | 200 |
Issued for directors converted loans (1) |  | 92,857 |  | $ | 0.34 |  |  | 31,308 |
Issued for parent company converted loans (2) |  | 152,857 |  | $ | 3.06 |  |  | 467,000 |
Issued for directors converted loans (3) |  | 21,429 |  | $ | 7.00 |  |  | 150,000 |
Issued for converted debt and accrued interest (4) |  | 44,350 |  | $ | 14.00 |  |  | 620,897 |
Issued in private placement (5) |  | 72,500 |  | $ | 14.00 |  |  | 1,014,948 |
Outstanding at December 31, 2019 |  | 383,996 |  |  |  |  | $ | 2,284,353 |
Issued in private placement (6) |  | 37,500 |  | $ | 28.00 |  |  | 1,050,000 |
Issued in private placement (6) |  | 12,082 |  | $ | 35.00 |  |  | 422,875 |
Issued in asset acquisition (7) |  | 9,957 |  | $ | 16.80 |  |  | 167,280 |
Issued for converted debt and accrued interest (8) |  | 6,523 |  | $ | 39.20 |  |  | 255,718 |
Issued for new converted debt and accrued interest (9) |  | 45,858 |  | $ | 28.96 |  |  | 1,328,163 |
Issued in private placement (10) |  | 229 |  | $ | 34.93 |  |  | 8,000 |
Issued for consulting services (11) |  | 871 |  | $ | 37.19 |  |  | 32,393 |
Issued for exercise of stock options (12) |  | 1,743 |  | $ | 44.80 |  |  | 78,080 |
Issued for performance bonus (13) |  | 14,929 |  | $ | 49.00 |  |  | 731,500 |
Issued in brokered private placement (14) |  | 62,994 |  | $ | 49.01 |  |  | 3,087,138 |
Shares from Foremost's QT (15) |  | 12,836 |  | $ | 49.00 |  |  | 628,949 |
Outstanding at September 30, 2020 |  | 589,518 |  |  |  |  | $ | 10,074,449 |
Less: share offering costs |  |  |  |  |  |  |  | (699,886 | )
Total share capital at September 30, 2020 |  |  |  |  |  |  | $ | 9,374,563 |
|  | September 30, 2022 |  |  | September 30, 2021 |  |  | September 30, 2020 |
|  | Number |  |  | Amount |  |  | Number |  |  | Amount |  |  | Number |  |  | Amount |
Balance, beginning of year |  | 699,511 |  | $ | 17,215,068 |  |  | 589,518 |  | $ | 9,374,563 |  |  | 383,996 |  | $ | 2,284,353 |
Issued in private placement |  | 22,857 |  | $ | 272,000 |  |  | 10,714 |  | $ | 1,110,000 |  |  | 49,811 |  | $ | 1,480,875 |
Issued for exercise of warrants |  | 19,000 |  | $ | 277,098 |  |  | 10,380 |  | $ | 815,307 |  |  | - |  | $ | - |
Issued for bonus shares relating to borrowings (Note 10) |  | 18,525 |  | $ | 411,692 |  |  | - |  | $ | - |  |  | - |  | $ | - |
Issued for conversion of share units |  | 8,349 |  | $ | 874,840 |  |  | 138 |  | $ | 12,498 |  |  | - |  | $ | - |
Issued for acquisition (Note 4(a)) |  | 3,965 |  | $ | 377,503 |  |  | - |  | $ | - |  |  | - |  | $ | - |
Issued for conversion of contingent shares (Note 4(a)) |  | 875 |  | $ | 83,319 |  |  | - |  | $ | - |  |  | - |  | $ | - |
Issued for debt settlements |  | 143 |  | $ | 19,000 |  |  | 1,305 |  | $ | 63,866 |  |  | - |  | $ | - |
Issued in brokered private placement |  | - |  | $ | - |  |  | 51,087 |  | $ | 3,611,818 |  |  | 62,994 |  | $ | 3,087,138 |
Issued for exercise of stock options |  | - |  | $ | - |  |  | 18,195 |  | $ | 1,292,015 |  |  | 1,743 |  | $ | 78,080 |
Issued for asset acquisition (Note 4(b)) |  | - |  | $ | - |  |  | 14,286 |  | $ | 1,290,000 |  |  | 9,957 |  | $ | 167,280 |
Issued for exercise of broker compensation options |  | - |  | $ | - |  |  | 2,459 |  | $ | 347,680 |  |  | - |  | $ | - |
Issued for amended license (Note 26) |  | - |  | $ | - |  |  | 1,429 |  | $ | 137,000 |  |  | - |  | $ | - |
Issued for conversion of 15% 2020 converted notes |  | - |  | $ | - |  |  | - |  | $ | - |  |  | 45,858 |  | $ | 1,328,163 |
Issued for performance bonus |  | - |  | $ | - |  |  | - |  | $ | - |  |  | 14,929 |  | $ | 731,500 |
Shares from Foremost's QT (Note 4(c)) |  | - |  | $ | - |  |  | - |  | $ | - |  |  | 12,836 |  | $ | 628,949 |
Issued for conversion of 10% 2019 converted notes |  | - |  | $ | - |  |  | - |  | $ | - |  |  | 6,523 |  | $ | 255,718 |
Issued for consulting services |  | - |  | $ | - |  |  | - |  | $ | - |  |  | 871 |  | $ | 32,393 |
Less: share offering costs for the year |  | - |  | $ | (33,880 | ) |  | - |  | $ | (839,679 | ) |  | - |  | $ | (699,886 | )
Balance, end of year |  | 773,225 |  | $ | 19,496,640 |  |  | 699,511 |  | $ | 17,215,068 |  |  | 589,518 |  | $ | 9,374,563 |
Disclosure of warrant activity [Table Text Block] |
|  | # of Warrants |  |  | Exercise Price |  |  | Fair Value |  |  | Weighted average remaining life (years) |  |  | Expiry Date |
Warrants outstanding at December 31 2018 |  | - |  | $ | - |  | $ | - |  |  | - |  |  |  |
Granted |  | 6,500,000 |  | $ | 0.20 |  | $ | 1,192 |  |  | 3.25 |  |  | January 1 2024 |
Granted |  | 2,000,000 |  | $ | 0.20 |  | $ | 19,858 |  |  | 3.71 |  |  | June 14 2024 |
Warrants outstanding at December 31, 2019 |  | 8,500,000 |  |  |  |  | $ | 1,192 |  |  |  |  |  |  |
Issued in private placement |  | 15,000 |  | $ | 0.40 |  | $ | 2,265 |  |  | 1.33 |  |  | January 30 2022 |
Issued in private placement |  | 84,622 |  | $ | 0.45 |  | $ | 13,515 |  |  | 1.60 |  |  | May 8 2022 |
Issued in asset acquisition (see Note 4) |  | 750,000 |  | $ | 0.50 |  | $ | 180,000 |  |  | 2.29 |  |  | June 12 2022 |
Issued in private placement |  | 235,428 |  | $ | 0.70 |  | $ | 60,340 |  |  | 1.77 |  |  | July 9 2022 |
Warrants outstanding at September 30, 2020 |  | 9,585,050 |  |  |  |  | $ | 257,312 |  |  | 3.22 |  |  |  |
|  | September 30, 2022 |  |  | September 30, 2021 |  |  | September 30, 2020 |
|  |  |  |  | Weighted |  |  |  |  |  | Weighted |  |  |  |  |  | Weighted |
|  | Number of |  |  | average |  |  | Number of |  |  | average exercise |  |  | Number of |  |  | average exercise |
|  | warrants |  |  | exercise price |  |  | warrants |  |  | price |  |  | warrants |  |  | price |
Outstanding, beginning of year |  | 13,901,640 |  | $ | 0.74 |  |  | 9,585,050 |  | $ | 0.24 |  |  | 8,500,000 |  | $ | 0.20 |
Issued |  | 1,000,000 |  | $ | 0.57 |  |  | 5,043,165 |  | $ | 1.73 |  |  | 1,085,050 |  | $ | 0.54 |
Exercised |  | (1,330,000 | ) | $ | 0.26 |  |  | (726,575 | ) | $ | 1.05 |  |  | - |  | $ | - |
Expired |  | (154,484 | ) | $ | 0.56 |  |  | - |  | $ | - |  |  | - |  | $ | - |
Outstanding, end of year |  | 13,417,156 |  | $ | 0.78 |  |  | 13,901,640 |  | $ | 0.74 |  |  | 9,585,050 |  | $ | 0.24 |
Exercisable, end of year |  | 12,792,156 |  | $ | 0.82 |  |  | 12,901,640 |  | $ | 0.75 |  |  | 8,835,050 |  | $ | 0.22 |
Disclosure of additional information on outstanding warrants [Table Text Block] |  |
|  | Number |  |  |  |  |  |  |
|  | outstanding |  |  | Fair value (1) |  |  | Expiry Date |
Founders' warrants: |  |  |  |  |  |  |  |  |
Exercise price of $0.20 |  | 5,520,000 |  | $ | 1,013 |  |  | January 1, 2024 |
Exercise price of $0.20 |  | 1,900,000 |  | $ | 18,865 |  |  | June 14, 2024 |
GhostStep's warrants: |  |  |  |  |  |  |  |  |
Exercise price of $0.50 |  | 250,000 |  | $ | 60,000 |  |  | January 15, 2023 |
April 2021 equity financing: |  |  |  |  |  |  |  |  |
Exercise price of $1.75 |  | 3,274,657 |  | $ | 785,918 |  |  | April 29, 2023 |
Exercise price of $1.75 |  | 40,000 |  | $ | 9,600 |  |  | August 25, 2023 |
LEC's warrants (see Note 4(b)): |  |  |  |  |  |  |  |  |
Exercise price of $0.70 |  | 500,000 |  | $ | 425,000 |  |  | April 29, 2026 |
September 2021 equity financing: |  |  |  |  |  |  |  |  |
Exercise price of $2.35 |  | 750,000 |  | $ | 390,000 |  |  | September 16, 2023 |
Broker warrants: |  |  |  |  |  |  |  |  |
Exercise price of $1.75 |  | 137,499 |  | $ | 33,000 |  |  | April 29, 2023 |
Exercise price of $2.00 |  | 45,000 |  | $ | 32,400 |  |  | September 16, 2023 |
Acquisition of Police Ordnance (Note 4(a)): |  |  |  |  |  |  |  |  |
Exercise price of $1.72 |  | 200,000 |  | $ | 132,000 |  |  | December 15, 2024 |
July 2022 equity financing |  |  |  |  |  |  |  |  |
Exercise price of $0.285 |  | 800,000 |  | $ | 72,000 |  |  | July 14, 2024 |
|  | 13,417,156 |  | $ | 1,959,796 |  |  |  |
Disclosure of weighted-average assumptions of warrants granted [Table Text Block] |
|  | Warrants @ $0.20 |
1/70 of stock price | $ | 0.044 |
Volatility |  | 66.75% |
Dividend Yield |  | Nil |
Risk-free interest rate |  | 1.40% |
Expected life |  | 5 |
Weighted average fair value per warrant | $ | 0.0099 |
|  | Warrants @ $0.40 |  |  | Warrants @ $0.45 |  |  | Warrants @ $0.70 |
1/70 of stock price | $ | 0.40 |  | $ | 0.50 |  | $ | 0.70 |
Volatility |  | 68% |  |  | 68% |  |  | 67% |
Dividend Yield |  | Nil |  |  | Nil |  |  | Nil |
Risk-free interest rate |  | 1.47% |  |  | 0.27% |  |  | 0.29% |
Expected life |  | 2 |  |  | 2 |  |  | 2 |
Estimated fair value per warrant | $ | 0.15 |  | $ | 0.20 |  | $ | 0.26 |
|  | Acquisition of POC |  |  | July 2022 Warrants |
Exercise Price | $ | 1.72 |  | $ | 0.285 |
1/70 of stock price | $ | 1.36 |  | $ | 0.215 |
Volatility |  | 84.7% |  |  | 90.5% |
Dividend Yield |  | Nil |  |  | Nil |
Risk-free interest rate |  | 1.04% |  |  | 3.12% |
Expected life |  | 3 |  |  | 2 |
Weighted average fair value per warrant | $ | 0.66 |  | $ | 0.09 |
|  | Barrier Option Model |  |  | Black-Scholes Option Model |
|  | April 2021 warrants |  |  | September 2021 warrants |  |  | September 2021 broker warrants |  |  | LEC warrants |
Exercise Price | $ | 1.75 |  | $ | 2.35 |  | $ | 2.00 |  | $ | 0.70 |
1/70 of stock price | $ | 1.01 |  | $ | 2.14 |  | $ | 2.14 |  | $ | 0.40 |
Volatility |  | 80% |  |  | 80% |  |  | 80% |  |  | 0% |
Dividend Yield |  | Nil |  |  | Nil |  |  | Nil |  |  | Nil |
Risk-free interest rate |  | 0.31% |  |  | 0.26% |  |  | 0.26% |  |  | 69.00% |
Barrier (accelerator on life of warrants) | $ | 3.00 |  | $ | 4.60 |  |  | N/A |  |  | N/A |
Rebate | $ | 1.25 |  | $ | 2.00 |  |  | N/A |  |  | N/A |
Expected life |  | 2 |  |  | 1 |  |  | 1 |  |  | 0.85 |
Weighted average fair value per warrant | $ | 0.24 |  | $ | 0.52 |  | $ | 0.72 |  | $ | 0.85 |
|  | Warrants @ |  |  | Warrants @ |  |  | Warrants |
|  | $0.40 |  |  | $0.45 |  |  | @ $0.70 |
1/70 of stock price | $ | 0.40 |  | $ | 0.50 |  | $ | 0.70 |
Volatility |  | 68% |  |  | 68% |  |  | 67% |
Dividend Yield |  | Nil |  |  | Nil |  |  | Nil |
Risk-free interest rate |  | 1.47% |  |  | 0.27% |  |  | 0.29% |
Expected life |  | 2 |  |  | 2 |  |  | 2 |
Estimated fair value per warrant | $ | 0.15 |  | $ | 0.20 |  | $ | 0.26 |
Disclosure of number and weighted average exercise prices of share options [Table Text Block] |
|  | Number of options |  |  | Weighted average exercise price |
Options outstanding at December 31, 2019 |  | - |  | $ | - |
Granted |  | 29,357 |  |  | 45.50 |
Options from the Foremost qualifying transaction |  | 1,224 |  |  | 32.90 |
Exercised |  | (1,743 | ) |  | 35.00 |
Options outstanding at September 30, 2020 |  | 28,838 |  | $ | 45.50 |
Options exercisable at September 30, 2020 |  | 7,474 |  | $ | 42.00 |
|  |  |  |  | Weighted |
|  | Number of |  |  | average |
|  | options |  |  | exercise price |
Outstanding at December 31, 2019 |  | - |  | $ | - |
Granted |  | 29,357 |  | $ | 45.50 |
Options from the Qualifying Transaction |  | 1,224 |  | $ | 32.90 |
Exercised |  | (1,743 | ) | $ | 35.00 |
Outstanding at September 30, 2020 |  | 28,838 |  | $ | 45.50 |
Granted |  | 52,988 |  | $ | 104.30 |
Exercised |  | (18,194 | ) | $ | 50.40 |
Cancelled |  | (4,096 | ) | $ | 48.30 |
Outstanding at September 30, 2021 |  | 59,536 |  | $ | 95.90 |
Granted |  | 9,500 |  | $ | 69.59 |
Cancelled |  | (11,928 | ) | $ | 131.76 |
Outstanding at September 30, 2022 |  | 57,108 |  | $ | 83.87 |
Options exercisable at September 30, 2022 |  | 43,618 |  | $ | 83.90 |
Disclosure of weighted-average assumptions of stock options granted [Table Text Block] |
Stock price | $28.00 to $49.00
Exercise price | $28.00 to $49.00
Volatility | 67.71%
Dividend Yield | Nil
Risk-free interest rate | 0.65%
Expected life (years) | 4.15
Weighted-average fair value per option | $ 16.10
|  | 2022 |  |  | 2021 |  |  | 2020 |
| $ | 14.70 to |  | $ | 49.00 to |  | $ | 28.00 to |
Stock price | $ | 126.70 |  | $ | 159.60 |  | $ | 49.00 |
| $ | 14.70 to |  | $ | 49.00 to |  | $ | 28.00 to |
Exercise price | $ | 126.70 |  | $ | 159.60 |  | $ | 49.00 |
Volatility |  | 90.48% |  |  | 76.46% |  |  | 67.71% |
Dividend yield |  | Nil |  |  | Nil |  |  | Nil |
Risk-free interest rate |  | 2.04% |  |  | 0.35% |  |  | 65.00% |
Expected life (years) |  | 2.91 |  |  | 2.26 |  |  | 3.38 |
Weighted-average fair value per option | $ | 38.21 |  | $ | 50.40 |  | $ | 16.10 |
Disclosure of range of exercise prices of outstanding share options [Table Text Block] |
Range of exercise prices |  | Number outstanding |  |  | Weighted average remaining contractual life |  |  | Number exercisable |
$33.00 |  | 1,224 |  |  | 2.71 |  |  | 1,224 |
$35.00 |  | 2,614 |  |  | 0.67 |  |  | - |
$46.00 |  | 13,214 |  |  | 4.41 |  |  | 3,304 |
$49.00 |  | 11,786 |  |  | 4.79 |  |  | 2,946 |
|  | 28,838 |  |  | 4.15 |  |  | 7,474 |
|  |  |  |  | Weighted |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  |  |  | average |  |  | Weighted |  |  |  |  |  | Remaining |  |  | Weighted |
Range of |  |  |  |  | remaining |  |  | average |  |  |  |  |  | exercisable |  |  | average |
exercise |  | Number |  |  | contractual |  |  | outstanding |  |  |  |  |  | contractual |  |  | exercisable |
prices |  | outstanding |  |  | life |  |  | strike price |  |  | Exercisable |  |  | life |  |  | strike price |
$14.70 to $41.16 |  | 4,592 |  |  | 4.54 |  | $ | 15.91 |  |  | 306 |  |  | 0.71 |  | $ | 32.90 |
$41.17 to $67.63 |  | 12,329 |  |  | 2.74 |  | $ | 48.74 |  |  | 12,329 |  |  | 2.74 |  | $ | 48.74 |
$67.64 to $94.10 |  | 20,973 |  |  | 3.47 |  | $ | 78.02 |  |  | 17,080 |  |  | 3.38 |  | $ | 75.79 |
$94.11 to 120.57 |  | 7,448 |  |  | 3.34 |  | $ | 118.59 |  |  | 7,448 |  |  | 3.34 |  | $ | 118.59 |
$120.58 to $147.00 |  | 11,766 |  |  | 3.95 |  | $ | 135.66 |  |  | 6,455 |  |  | 3.97 |  | $ | 134.87 |
|  | 57,108 |  |  | 3.48 |  | $ | 83.87 |  |  | 43,618 |  |  | 3.26 |  | $ | 83.90 |
Disclosure of changes in share units [Table Text Block] |  |
|  | RSUs |  |  | PSUs |  |  | SARs |  |  | Total |
Outstanding at September 30, 2020 |  | - |  |  | - |  |  | - |  |  | - |
Granted |  | 16,412 |  |  | 2,857 |  |  | 2,143 |  |  | 21,412 |
Vested and converted |  | (139 | ) |  | - |  |  | - |  |  | (139 | )
Outstanding at September 30, 2021 |  | 16,273 |  |  | 2,857 |  |  | 2,143 |  |  | 21,273 |
Granted |  | 10,726 |  |  | 17,942 |  |  | 514 |  |  | 28,668 |
Vested and converted to common shares |  | (5,681 | ) |  | (2,666 | ) |  | - |  |  | (8,347 | )
Vested and repurchased for withholding taxes |  | (144 | ) |  | (249 | ) |  | - |  |  | (393 | )
Expired / cancelled |  | - |  |  | (17,714 | ) |  | - |  |  | (17,714 | )
Outstanding at September 30, 2022 |  | 21,174 |  |  | 170 |  |  | 2,657 |  |  | 24,001 |
Disclosure of share based compensation expense by function [Table Text Block] |  |
|  | Year ended |  |  | Year ended |  |  | Nine months ended |
|  | September 30, |  |  | September 30, |  |  | September 30, |
|  | 2022 |  |  | 2021 |  |  | 2020 |
General and administrative | $ | 1,104,858 |  | $ | 1,425,111 |  | $ | 160,267 |
Selling and marketing |  | 552,627 |  |  | 754,167 |  |  | 42,700 |
Research and development, net |  | 302,587 |  |  | 282,929 |  |  | 80,117 |
Total share-based compensation | $ | 1,960,072 |  | $ | 2,462,207 |  | $ | 283,084 |

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfClassesOfShareCapitalAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of issued capital. [Refer: Issued capital] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2022-03-24 -Paragraph 10 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_10_e&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DisclosureOfIssuedCapitalExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 45 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the range of exercise prices for outstanding share options. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 45 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_d&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of additional information on the outstanding warrants. + References No definition available. + Details
Name: | kwe_DisclosureOfAdditionalInformationOnOutstandingWarrantsExplanatory
Namespace Prefix: | kwe_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the changes in share units. + References No definition available. + Details
Name: | kwe_DisclosureOfChangesInShareUnitsExplanatory
Namespace Prefix: | kwe_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of share based compensation expense by function. + References No definition available. + Details
Name: | kwe_DisclosureOfShareBasedCompensationExpenseByFunctionExplanatory
Namespace Prefix: | kwe_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of weighted-average assumptions of stock options granted. + References No definition available. + Details
Name: | kwe_DisclosureOfWeightedAverageAssumptionsOfStockOptionsGrantedExplanatory
Namespace Prefix: | kwe_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The tabular disclosure of the weighted-average assumptions of warrants granted. + References No definition available. + Details
Name: | kwe_DisclosureOfWeightedAverageAssumptionsOfWarrantsGrantedExplanatory
Namespace Prefix: | kwe_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration